Found vs Mochi Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

Mochi Health beats Found overall, scoring 7.7/10 vs 7.3/10. Mochi Health is more affordable at $178/mo vs $264/mo. Choose Found for users who want a science-backed weight loss program with beh. Choose Mochi Health for users who want a tech-forward platform with app-based tracki.

A side-by-side comparison of Found and Mochi Health covering pricing, scores, medication types, insurance, and more to help you decide.

Found

#37 of 48
7.3/10

Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.

Visit Found
Higher Rated

Mochi Health

#20 of 48
7.7/10

Tech-forward GLP-1 platform with a sleek app for tracking progress, medications, and provider communications.

Visit Mochi Health
FeatureFoundMochi Health
Our Score7.3/107.7/10
Starting Price$264/mo$178/mo
Medication TypeBothCompounded
Insurance AcceptedYesNo
Best ForUsers who want a science-backed weight loss program with behavior change supportUsers who want a tech-forward platform with app-based tracking
Ranking#37#20

Pros & Cons Compared

Found

Pros

  • +Active insurance coordination — Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
  • +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill) — the widest formulary of any platform
  • +Typical insured copay of ~$30/mo for most members — dramatically lower than cash-pay alternatives
  • +Most members start treatment within one week of completing the health questionnaire

Cons

  • Pricing is less transparent than flat-rate competitors — costs vary by insurance status and medication choice
  • The insurance navigation process adds steps and complexity compared to simple cash-pay platforms
  • Compounded medication availability may shift with FDA enforcement changes

Mochi Health

Pros

  • +Flat $99/mo semaglutide at ALL dose levels — saves $100-200/mo vs competitors who charge more at higher doses
  • +4 semaglutide formats: injection, oral tablet, oral drops, and microdose — the most delivery options of any platform
  • +Registered dietitians included alongside physicians — not just medication, but nutritional support
  • +Both compounded and brand-name medications available (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus)

Cons

  • Separate $79/mo membership fee makes the real cost ~$178/mo for semaglutide, not the advertised $99
  • No refunds for payments made over 30 days ago — limited consumer protection window
  • Relatively new company (founded 2022) with less track record than established platforms

Our Verdict

Mochi Health edges out Found with a score of 7.7/10 vs 7.3/10. If budget is your priority, Mochi Health starts at $178/mo compared to Found's $264/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Found if you want: users who want a science-backed weight loss program with behavior change support. Choose Mochi Health if you want: users who want a tech-forward platform with app-based tracking.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Found nor Mochi Health feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try Found

Starting at $264/mo

Visit Found

Try Mochi Health

Starting at $178/mo

Visit Mochi Health

Related comparisons

Other matchups readers comparing Found or Mochi Health tend to look at next.

Top Picks

Four programs our readers click through most.

Eden Health GLP-1

8.9/10
$249/mo·Brand & Compounded

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.